Genetic Analysis of Pediatric Psoriasis
NCT03768284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86
Last updated 2022-04-20
Summary
This study will ascertain approximately 150 subjects, which will include pediatric psoriasis patients diagnosed before age 12, parents not affected by psoriasis, and if a family history is indicated, up to third-degree family members. Saliva (or buccal swabs in the case of infants) will be obtained for DNA isolation.
Conditions
Interventions
- OTHER
-
Saliva or buccal sample
Saliva or buccal sample
Sponsors & Collaborators
-
National Psoriasis Foundation
collaborator OTHER -
Icahn School of Medicine at Mount Sinai
collaborator OTHER - lead OTHER
Principal Investigators
-
Amy Paller, MD · Northwestern University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-17
- Primary Completion
- 2021-06-30
- Completion
- 2021-12-30
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
NCT00755196 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis
NCT00111111 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis
NCT01100034 ·Status: COMPLETED
-
Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
NCT00563524 ·Status: COMPLETED ·Phase: PHASE1
-
Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis
NCT07340216 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
NCT02239666 ·Status: COMPLETED
-
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01276639 ·Status: COMPLETED ·Phase: PHASE3
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis
NCT00141921 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
NCT02274792 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
NCT00759161 ·Status: COMPLETED ·Phase: PHASE2
-
Body PSOriasis: Long-term Relapse CONTROL
NCT03402828 ·Status: COMPLETED
-
Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis
NCT03475914 ·Status: COMPLETED
-
Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects
NCT00111436 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
NCT00195507 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
NCT00161655 ·Status: COMPLETED ·Phase: PHASE4
-
Peds Metabolic Syndrome in Psoriasis
NCT00930592 ·Status: COMPLETED
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
Topical CP-690,550 For Chronic Plaque Psoriasis
NCT00678561 ·Status: COMPLETED ·Phase: PHASE2
-
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01309737 ·Status: COMPLETED ·Phase: PHASE3
-
ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
NCT05122039 ·Status: RECRUITING
-
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
NCT00617994 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Analysis of Small and Large Plaque Psoriasis
NCT01920906 ·Status: COMPLETED ·Phase: NA
-
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
NCT00769184 ·Status: COMPLETED ·Phase: NA
-
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
NCT07298265 ·Status: RECRUITING